Has venture capital always been a bad model for the life sciences?
Andrew Lo, director of the MIT Laboratory for Financial Engineering, dismissed the sector outright on stage Sunday at the Cleveland Clinic Medical Innovation Summit. His rationale:
{iframe}http://medcitynews.com/2015/10/is-venture-capital-bad-for-life-sciences-3-reasons-why-and-what-should-replace-it/?utm_source=MedCity+News+Subscribers&utm_campaign=f6365420d6-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-f6365420d6-408826397{/iframe}